Amphastar Pharmaceuticals Inc (STU:29A)
€ 43.12 -6.39 (-12.91%) Market Cap: 2.08 Bil Enterprise Value: 2.43 Bil PE Ratio: 17.05 PB Ratio: 3.59 GF Score: 89/100

Q1 2019 Amphastar Pharmaceuticals Inc Earnings Call Transcript

May 09, 2019 / 09:00PM GMT
Release Date Price: €19.84 (-0.32%)
Operator

Good day, ladies and gentlemen, and welcome to Amphastar first quarter earnings conference call. (Operator Instructions)

All statements on this conference call that are not historical are forward-looking statements, including, among other things, statements relating to the company's expectation regarding future financial performance; backlog; sales and marketing of its product; market size and growth; the timing of FDA filings or approvals, including the DMF of ANP; the timing of the product launches; acquisitions and other matters related to its pipeline of product candidates; its share buyback program and other future events.

These statements are not historical facts but rather are based on Amphastar's historical performance and its current expectations, estimates and projections regarding Amphastar's business operations and other similar or related factors. Words such as may, might, will, could, would, should, anticipate, predict, potential, continue, expect, intend, plan, project, belief, estimate and other similar or related expressions are used to identify these forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot